newsfilter
← Latest News
Business Wire·

Pear Therapeutics to Issue Third Quarter 2022 Financial Results on Monday, November 14, 2022

Pear Therapeutics, Inc. (the "Company") (NASDAQ:PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced it will issue its third